Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India

Microbial Pathogenesis

Volumn 53, Issue 2, 2012, Pages 81-86

  Tiwari, Vishvanath ^a   Kapil, Arti ^a   Moganty, Rajeswari R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

lactamase; lactams; Acinetobacter baumannii; Carbapenem resistance; OXA 51

Indexed keywords

BETA LACTAMASE; CARBAPENEM; DEXTRO SERINE; NITROCEFIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; GENE AMPLIFICATION; GENOME ANALYSIS; INDIA; ISOELECTRIC FOCUSING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; SEQUENCE ANALYSIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; BETA-LACTAMASES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; HUMANS; HYDROLYSIS; INDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA;

ACINETOBACTER BAUMANNII; NEGIBACTERIA;

EID: 84862771888     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.05.004     Document Type: Article

References (46)

1. Munoz-Price L.S., Weinstein R.A. Acinetobacter infection. N Engl J Med 2008, 358:1271-1281.
2. Chuang Y., Chang S., Wang W. High and increasing Oxa-51 DNA load predict mortality in Acinetobacter baumannii Bacteremia: implication for pathogenesis and evaluation of therapy. PLoS ONE 2010, 5(11):e14133.
3. Toniolo A., Endimiani A., Luzzaro F. Microbiology of postoperative infections. Surg Infect (Larchmt) 2006, 7:S13-S16.
4. Gupta E., Mohanty S., Sood S., Dhawan B., Das B.K., Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Ind J Med Res 2006, 124(1):95-98.
5. Neonakis I.K., Spandidos D.A., Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents 2011, 37(2):102-109.
6. Vila J., Pachon J. Therapeutic options for Acinetobacter baumannii infections. Expert Opin Pharmacother 2008, 9(4):587-599.
7. Doi Y., Husain S., Potoski B.A., McCurry K.R., Paterson D.L. Extensively drug resistant Acinetobacter baumannii. Emerg Infect Dis 2009, 15:980-982.
8. Zavascki A.P., Carvalhaes C.G., Picao R.C., Gales A.C. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther 2010, 8:71-93.
9. Acosta J., Merino M., Viedma E., Poza M., Sanz F., Otero J.R., et al. Multidrug-resistant Acinetobacter baumannii harboring OXA-24 carbapenemase, Spain. Emerg Infect Dis 2011, 17:6.
10. Brown S., Young H.K., Amyes S.G.B. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect 2005, 11:11-15.
11. Rodríguez-Martínez J., Poirel L., Nordmann P. Genetic and functional variability of AmpC-Type β-Lactamases from Acinetobacter baumannii. Antimicrob Agents Chemother 2010, 54(11):4930-4933.
12. Santella G., Docquier J., Gutkind G., Rossolini G.M., Radice M. Purification and biochemical characterization of IMP-13 metallo-β-lactamase. Antimicrob Agents Chemother 2011, 399-401.
13. Fernandez-Cuenca F., Martinez-Martinez L., Conejo M.C., Ayala J.A., Perea E.J., Pascual A. Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 2003, 51:565-574.
14. Malouin F., Bryan L.E. Modification of penicillin-binding proteins as mechanisms of β-lactam resistance. Antimicrob Agents Chemother 1986, 30:1-5.
15. Vashist J., Tiwari V., Das R., Kapil A., Rajeswari M.R. Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii. Ind J Med Res 2011, 133:332-338.
16. Vashist J., Tiwari V., Kapil A., Rajeswari M.R. Quantitative profiling and identification of outer membrane proteins of β-Lactam resistant strain of Acinetobacter baumannii. J Proteome Res 2010, 9:1121-1128.
17. Hu W.S., Yao S., Hsieh C.F., Liu C., Lin J. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51(11):3844-3852.
18. Vila J., Mart S., Sanchez-Cespedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007, 59:1210-1215.
19. Wilke M.S., Lovering A.L., Strynadka N.C.J. Beta-Lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 2005, 8:525-533.
20. Bush K., Jacoby G.A., Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39:1211-1233.
21. Costa L., Coelho M.J.M., Souza H., Castro M., Stier C.J.N., Bragagnolo K.L., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003, 41:3403-3406.
22. Culebras E., González-Romo F., Head J., Gómez M., Morales G., Picazo J.J. Outbreak of Acinetobacter baumannii producing OXA-66 in a Spanish hospital: epidemiology and study of patient movements. Microb Drug Res 2010, 16(4):309-315.
23. Papa A., Koulourida V., Souliou E. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established greek hospital. Microb Drug Res 2009, 15:4.
24. Paton R., Miles R.S., Hood J., Amyes S.G., Miles R.S., Amyes S.G. ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993, 2:81-88.
25. Brown S., Amyes S. OXA β-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 2006, 57:1-3.
26. Walther-Rasmussen J., Høiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006, 57:373-383.
27. Chaulagain B.P., Jang S.J., Ahn G.Y., Ryu S.Y., Kim D.M., Park G., et al. Molecular epidemiology of an outbreak of imipenem-resistant Acinetobacter baumannii carrying the ISAba1-blaOXA-51-like genes in a Korean hospital. Jpn J Infect Dis 2012, 65:162-166.
28. Endo S., Yano H., Hirakata Y., Arai K., Kanamori H., Ogawa M., et al. Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan. J Antimicrob Chemother 2012; March 23.
29. Shahcheraghi F., Abbasalipour M., Feizabadi M.M., Ebrahimipour G.H., Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microb 2011, 3(2):68-74.
30. Lin W.R., Lu P.L., Siu L.K., Chen T., Lin C., Hung C., et al. Rapid control of a hospital-wide outbreak caused by extensively drug-resistantOXA-72-producing Acinetobacter baumannii. Kaohsiung J Med Sci 2011, 27:207-214.
31. Alsultan A.A., Hamouda A., Evans B.A., Amyes S.G. Acinetobacter baumannii: emergence of four strains with novel bla(OXA-51-like) genes in patients with diabetes mellitus. J Chemother 2009, 21(3):290-295.
32. Merkier A.K., Centron D. bla OXA-51-type β-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents 2006, 28:110-113.
33. Vahaboglu H., Budak F., Kasap M., Gacar G., Torol S., Karadenizli A., et al. High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 2006, 58:537-542.
34. Constantiniu S., Romaniuc A., Iancu L.S., Filimon R., Taraşi I. Cultural and biochemical characteristics of Acinetobacter spp. strains isolated from hospital units. J Prevent Med 2004, 12:35-42.
35. Matthew M., Harris A.M., Marshall M.J., Ross G. The use analytical isoelectric focusing for detection and identification of beta-lactamases. J General Microbiol 1975, 88:169-178.
36. Chu Y., Afzal-Shah M., Houang E.T.S., Palepou Marie-France I., Lyon D.J., Woodford N., et al. IMP-4 a novel metallo- β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 2001, 45(3):710-714.
37. Loo R.R.O., Stevenson T.I., Mitchell C., Loo J.A., Andrews P.C. Mass spectrometry of proteins directly from polyacrylamide gels. Anal Chem 1996, 68:1910-1917.
38. Bou G., Martinez-Beltran J. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-Lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2000, 44(2):428-432.
39. OXA genes among Acinetobacter spp. isolated from patients at Tehran hospital. Jpn J Infect Dis 2008, 61:274-278.
40. Yang H.Y., Lee H.J., Suh J.T., Lee K.M. Outbreaks of Imipenem resistant Acinetobacter baumannii producing OXA-23 β-Lactamase in a tertiary care hospital in Korea. Yonsei Med J 2009, 50:764-770.
41. Lee H., Chen C., Wang S., Sud L., Chen S., Liue S., et al. Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implications. Int J Antimicrob Agents 2011, 37:302-308.
42. Achour N.B., Mercuri P.S., Moussa M.B., Galleni M., Belhadj O. Characterization of a novel extended-spectrum TEM-type β-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia. Microb Drug Res 2009, 15(3):195-199.
43. Jacoby G.A. AmpC beta-lactamases. Clin Microbiol Rev 2009, 22(1):161-182.
44. Galesa A.C., Tognima M.C.B., Reisa A.O., Jonesc R.N., Sadera H.S. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbio Infec Dis 2003, 45:77-79.
45. Paetzel M., Danel F., Castro L., Mosimann S.C., Page M.G., Strynadka N.C. Crystal structure of the classD β-lactamase OXA-10. Nat Struct Biol 2000, 7:918-925.
46. Poirel S.F.L., Papa A., Koulourida V., Nordmann P. Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba. Antimicrob Agents Chemother 2009, 53(9):4045-4047.